Your browser doesn't support javascript.
loading
A case of skin rash during oral administration of a novel androgen receptor inhibitor, darolutamide.
Shima, K; Nomura, T; Yamada, Y; Kobayashi, T; Kabashima, K.
Affiliation
  • Shima K; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Nomura T; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yamada Y; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kobayashi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kabashima K; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
J Eur Acad Dermatol Venereol ; 36(7): e554-e557, 2022 07.
Article in En | MEDLINE | ID: mdl-35184345
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Exanthema Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Androgen / Exanthema Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2022 Document type: Article Affiliation country: